Clinical Trials Browser

Phase 2 × Pluvicto × Gastrointestinal × Clear all

NCT06852820 2025-09-23

68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC)

Phase 2 Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms